Profil
Justine E.
Koenigsberg was the founder of Concert Pharmaceuticals, Inc., founded in 2008, where the title held was Director-Communications & Investor Relations from 2011 to 2014.
Current jobs include Member at National Investor Relations Institute and Vice President-Investor Relations at Kymera Therapeutics, Inc. starting in 2023.
Former jobs include Director-Corporate Communications at Transkaryotic Therapies, Inc., Director-Investor & Media Relations at ViaCell, Inc., and Principal at Vertex Pharmaceuticals, Inc. Education includes undergraduate studies at Northeastern University.
Postes actifs de Justine Koenigsberg
| Sociétés | Poste | Début |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Investor Relations Contact | 01/07/2023 |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
Anciens postes connus de Justine Koenigsberg
| Sociétés | Poste | Fin |
|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Fondateur | 01/05/2023 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Public Communications Contact | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Public Communications Contact | - |
Formation de Justine Koenigsberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
















